Microtubule inhibitors

Microtubule inhibitors

RHS

RHS

Viral structure and functions
Rhinovirus
Adenovirus
Influenza virus
Human parainfluenza viruses
Respiratory syncytial virus
Staphylococcus aureus
Streptococcus viridans
Streptococcus pyogenes (Group A Strep)
Streptococcus pneumoniae
Corynebacterium diphtheriae (Diphtheria)
Enterococcus
Upper respiratory tract infection
Allergic rhinitis
Bacillus anthracis (Anthrax)
Nocardia
Enterobacter
Yersinia enterocolitica
Pseudomonas aeruginosa
Klebsiella pneumoniae
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Bacteroides fragilis
Yersinia pestis (Plague)
Moraxella catarrhalis
Francisella tularensis (Tularemia)
Bordetella pertussis (Whooping cough)
Haemophilus influenzae
Pasteurella multocida
Mycobacterium tuberculosis (Tuberculosis)
Mycobacterium leprae
Mycobacterium avium complex (NORD)
Mycoplasma pneumoniae
Chlamydia pneumoniae
Coxiella burnetii (Q fever)
Epstein-Barr virus (Infectious mononucleosis)
Human herpesvirus 6 (Roseola)
Human herpesvirus 8 (Kaposi sarcoma)
Parvovirus B19
Mumps virus
Measles virus
Zika virus
Rubella virus
Candida
Plasmodium species (Malaria)
Asthma: Clinical
Pneumonia
Pneumonia: Pathology review
Respiratory distress syndrome: Pathology review
Restrictive lung diseases
Restrictive lung diseases: Pathology review
Sarcoidosis
Hypersensitivity pneumonitis
Obstructive lung diseases: Pathology review
Tuberculosis: Pathology review
Type IV hypersensitivity
Bartonella henselae (Cat-scratch disease and Bacillary angiomatosis)
Sinusitis
Laryngitis
Retropharyngeal and peritonsillar abscesses
Bacterial epiglottitis
Congenital pulmonary airway malformation
Acute respiratory distress syndrome
Emphysema
Asthma
Bronchiectasis
Cystic fibrosis
Alpha 1-antitrypsin deficiency
Chronic bronchitis
Idiopathic pulmonary fibrosis
Lung cancer
Superior vena cava syndrome
Pancoast tumor
Pneumothorax
Mesothelioma
Pleural effusion
Pulmonary embolism
Pulmonary hypertension
Pulmonary edema
Cystic fibrosis: Pathology review
Deep vein thrombosis and pulmonary embolism: Pathology review
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Lung cancer and mesothelioma: Pathology review
Iron deficiency anemia
Beta-thalassemia
Alpha-thalassemia
Sideroblastic anemia
Anemia of chronic disease
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Autoimmune hemolytic anemia
Sickle cell disease (NORD)
Aplastic anemia
Folate (Vitamin B9) deficiency
Vitamin B12 deficiency
Acute intermittent porphyria
Hemophilia
Hemolytic-uremic syndrome
Thrombotic thrombocytopenic purpura
Immune thrombocytopenia
Von Willebrand disease
Disseminated intravascular coagulation
Heparin-induced thrombocytopenia
Hodgkin lymphoma
Non-Hodgkin lymphoma
Chronic leukemia
Acute leukemia
Myelodysplastic syndromes
Polycythemia vera (NORD)
Myelofibrosis (NORD)
Essential thrombocythemia (NORD)
Mastocytosis (NORD)
Microcytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Heme synthesis disorders: Pathology review
Coagulation disorders: Pathology review
Platelet disorders: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Thrombosis syndromes (hypercoagulability): Pathology review
Lymphomas: Pathology review
Leukemias: Pathology review
Plasma cell disorders: Pathology review
Myeloproliferative disorders: Pathology review
Bronchioles and alveoli histology
Trachea and bronchi histology
Lung volumes and capacities
Alveolar surface tension and surfactant
Ventilation
Zones of pulmonary blood flow
Regulation of pulmonary blood flow
Pulmonary shunts
Ventilation-perfusion ratios and V/Q mismatch
Airflow, pressure, and resistance
Gas exchange in the lungs, blood and tissues
Diffusion-limited and perfusion-limited gas exchange
Blood histology
Blood components
Erythropoietin
Ribonucleotide reductase inhibitors
Topoisomerase inhibitors
Platinum containing medications
Anti-tumor antibiotics
Microtubule inhibitors
DNA alkylating medications
Monoclonal antibodies
Antimetabolites for cancer treatment
Antimalarials

Transcript

Watch video only

Microtubule inhibitors, as their name implies, disrupt the microtubules and inhibit mitosis, which is a specific phase of the cell cycle.

Anticancer agents in this class include the vinca alkaloids and the taxanes.

But first things first.

The cytoskeleton is a network of proteins within the cell that gives each cell its shape, and it anchors organelles in place.

But it’s also a dynamic network, which can change shape when the cell wants to move, contract, divide, or pull in or push out molecules.

It’s made up of three proteins: actin filaments, intermediate filaments, and microtubules.

Microtubules are made of alternating round proteins called α- and β-tubulins, which form long strands called protofilaments.

Thirteen of these protofilaments come together to form a single microtubule.

Microtubules play a super important role in cell division.

During cell division there are two centrosomes inside the cell, and each centrosome is made out of two centrioles.

Each centriole is in turn made up of nine sets of microtubule triplets.

Now cell division, or mitosis, can be divided into four subphases: prophase, metaphase, anaphase, and telophase.

During prophase, the membrane around the nucleus disintegrates, and the chromosomes condense.

During metaphase, chromosomes move towards the middle of the cell, on a line called the metaphase plate.

Each chromosome is made up of a pair of sister chromatids which are joined together in the centromere where there’s a specific protein complex called the kinetochore.

When the chromosomes are in place, each centrosome sends out thread-like projections called spindle fibers, that attach to the centromere of each chromosome.

Spindle fibers consist of microtubules that originate from the centrioles and polymerize in the direction of the kinetochores.

Next, during anaphase, the centrosomes start pulling on the spindle fibers to pull the sister chromatids apart, forming the mitotic spindle.

It looks a bit like a fishing line being cast out to its target, and then the line gets reeled in, pulling the kinetochore and it’s attached sister chromatid away from its partner chromosome.

Finally, there’s the telophase during which a nuclear membrane forms around each new set of 46 single-chromatid chromosomes.

After that, during cytokinesis, the cell membrane pinches in until the two daughter cells separate.

Alright, now cancer cells replicate rapidly so they are constantly undergoing mitosis and the microtubules are always at work.

This means that microtubule inhibitors will affect these cells more than our healthy cells, most of which only divide occasionally.

Interfering with the formation of microtubules will cause mitosis to fail and the cell will eventually die without replicating.

The two commonly used anticancer microtubule inhibitors include the vinca alkaloids and the taxanes.

All anticancer microtubule inhibitors are given intravenously.

Okay, let’s start with vinca alkaloids, which include vinblastine, and vincristine.

Vinca alkaloids bind to β-tubulin and block its polymerization into protofilaments, which form microtubules, centrioles, centrosomes, and spindle fibers.

This means the cell can’t form stable mitotic spindles and will stop at metaphase.

So, vinca alkaloids act in the M phase of the cell-cycle and are cell-cycle specific.

Moving on to indications.

Vinca alkaloids are used for solid tumors like: breast cancer; pediatric tumors like rhabdomyosarcoma and nephroblastoma or Wilms tumor; and leukemias.

Now, vincristine and vinblastine are both used for Hodgkin’s and non-Hodgkin’s lymphoma.

Let’s move on to side effects.

Vinca alkaloids disrupt the progression of mitosis in all rapidly dividing cells in the body including hair follicles and gastrointestinal epithelium, so vinblastine and vincristine cause alopecia, or loss of hair, and gastrointestinal symptoms.

In addition, they are associated with bone marrow suppression since the cells here are constantly making the platelets, red, and white blood cells.

Now, vinblastine causes more bone marrow suppression, but vincristine is more neurotoxic as it interferes with microtubule polymerization in neuronal axons disrupting the neuronal activity.

Neurotoxicity usually manifests as peripheral neuropathy causing symptoms like a decrease in sensation in the toes and fingers, sometimes called a glove and stocking distribution, as well as autonomic nervous system malfunction with orthostatic hypotension, urinary retention, and constipation.

Alright, next are the taxanes, which are also alkaloid derivatives, and include paclitaxel and docetaxel.

Taxanes also act on microtubules, but they act differently from vinca alkaloids.

Key Takeaways

Microtubules are a component of the cytoskeleton which are involved in cellular transport and cell division. Microtubule inhibitors work by disrupting the function of microtubules, which stops or slows down cell division and movement. This can be useful in cancer treatment, as it can stop or slow down the spread of cancer cells. Some common microtubule inhibitors include paclitaxel (Taxol) and vincristine.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "A microtubule bestiary: structural diversity in tubulin polymers" Molecular Biology of the Cell (2017)
  5. "Cell division: The renaissance of the centriole" Current Biology (1999)
  6. "Cancer Management" UBM Medica (2008)
  7. "Mechanism of taxane neurotoxicity" Breast Cancer (2004)
  8. "Docetaxel" Drugs (2005)